“…In their well-written letter, Altay et al [1 ]describe a possible mechanism for the observed elevated risk of mortality in the group of patients with low levels of HbA 1c (<5%). This interesting association is the central focus of an ongoing debate, with data showing low levels of HbA 1c to have an important impact on patients' prognosis, while other data do not support this notion [2,3,4,5].…”